Sign In
Buy OPK
$1.46
+0.0600 (+4.29%)
At Close: Jun 03, 2026
OPKO Health to Present at the 43rd Annual J.P. Morgan Healthcare Conference
11:45am, Thursday, 09'th Jan 2025
MIAMI, Jan. 09, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (Nasdaq: OPK) announced today that management will be participating in the 43r d Annual J.P. Morgan Healthcare Conference, being held January
Here's Why You Should Retain OPKO Health Stock in Your Portfolio
08:56am, Thursday, 09'th Jan 2025
OPK's growth is fueled by Rayaldee's success and accelerated clinical trials. However, stiff competition and overdependence on its lead product are concerns.
OPKO Health Announces Progress in EBV Vaccine Study, Stock Gains
10:15am, Wednesday, 08'th Jan 2025
OPK aims to advance a novel vaccine candidate for EBV infection, provide protective immunity to patients and prevent these diseases.
3 Stocks That Wall Street Insiders Can't Stop Buying
11:06am, Monday, 30'th Dec 2024
Insider activity is hot in names like Vestis NYSE: VSTS, OPKO Health NASDAQ: OPK, and Greif, Inc. NYSE: GEF, and investors should take notice. From board members to CEOs, CFOs, and other corporate of
NextPlat to Showcase OPKO Healthcare Products at the 2024 China International Natural Health & Nutrition Expo
08:00am, Monday, 18'th Nov 2024
OPKO Healthcare's Veterinary Care Products to be Introduced at Asia's Largest Health and Nutrition Tradeshow Company Invited to Present at Special Event Hosted by U.S. Consulate General During the Exp
OPK Stock Gains Following Q3 Earnings Beat, Gross Margin Contracts
01:15pm, Friday, 08'th Nov 2024
Lower revenues from OPKO Health's products and services dampen its overall third-quarter 2024 performance.
Here's What Key Metrics Tell Us About OPKO Health (OPK) Q3 Earnings
09:00pm, Thursday, 07'th Nov 2024
Although the revenue and EPS for OPKO Health (OPK) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare with Wall
OPKO Health, Inc. (OPK) Q3 2024 Earnings Conference Call Transcript
08:30pm, Thursday, 07'th Nov 2024
OPKO Health, Inc. (NASDAQ:OPK ) Q3 2024 Earnings Conference Call November 7, 2024 4:30 PM ET Company Participants Yvonne Briggs - Alliance Advisor, IR Phillip Frost - Chairman and CEO Elias Zerhouni -
OPKO Health (OPK) Q3 Earnings Surpass Estimates
07:41pm, Thursday, 07'th Nov 2024
OPKO Health (OPK) came out with quarterly earnings of $0.03 per share, beating the Zacks Consensus Estimate of a loss of $0.10 per share. This compares to loss of $0.11 per share a year ago.
OPK Gets Additional BARDA Funding to Develop Multispecific Antibodies
10:20am, Friday, 11'th Oct 2024
OPKO Health's receipt of the additional funding from BARDA is expected to explore the MSTAR platform to prepare for outbreaks and respond rapidly to emerging viral threats.
WESTON, Mass., Oct. 07, 2024 (GLOBE NEWSWIRE) -- ModeX Therapeutics Inc., an OPKO Health, Inc. (NASDAQ: OPK) company, announces it has been awarded $35 million of additional funding under an existing
Company to Support the Sales and Marketing of OPKO's Products on Additional E-Commerce Platforms and on Social Media Channels in China and into the Large Japanese Health and Wellness Market COCONUT GR
Here's Why You Should Retain OPKO Health Stock in Your Portfolio
12:56pm, Wednesday, 02'nd Oct 2024
OPK's growth is fueled by Rayaldee's success and strategic partnerships. However, stiff competition and overdependence on its lead product are concerns.
ENTX & OPK Stock May Gain Following Positive PK/PD Research Data
01:56pm, Thursday, 26'th Sep 2024
Entera and OPKO Health announce positive PK/PD results from their ongoing collaborative research focused on developing the first oral dual agonist GLP-1/glucagon peptide.
Labcorp Completes Acquisition of Select Assets of BioReference Health's Diagnostics Business from OPKO Health
07:30am, Monday, 16'th Sep 2024
Enhances Labcorp's laboratory services network and expands access to its clinical services BURLINGTON, N.C. and MIAMI , Sept.
